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PREFACE
A memorandum of understanding has been signed by two government agencies in the United 
States and Sweden—the Division of Standards Development and Technology Transfer, National 
Institute for Occupational Safety and Health (DSDTT/NIOSH), U.S. Department of Health and 
Human Services; and the Criteria Group of Occupational Standards Setting, Swedish National 
Institute of Occupational Health (NIOH). The purpose of the memorandum is to exchange 
information and expertise in the area of occupational safety and health. One product of this 
agreement is the development of documents to provide the scientific basis for establishing 
occupational exposure limits. These limits will be developed separately by the two countries 
according to their different national policies.
This document on the health effects of occupational exposure to 2-ethyl-2-hydroxymethyl-1,3- 
propanediol (trimethylolpropane) is the sixth product of that agreement. The document was 
written by Dr. Robert Walinder, Department of Occupational Medicine, University Hospital, 
Uppsala, Sweden, and was reviewed by the Criteria Group and by DSDTT/NIOSH.
Richard W. Niemeier, Ph.D. 
Director, DSDTT 
National Institute for 
Occupational Safety and Health
Bo Holmberg, Ph.D.
Chairman, Criteria Group 
National Institute of Occupational 
Health
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ABBREVIATIONS
ACGIH American Conference of Governmental Industrial Hygienists
BIBRA British Industrial Biological Research Association
b.wt. body weight
CNS central nervous system
CAS RN Chemical Abstracts Service Registry Number, of the American Chemical Society
EPA Environmental Protection Agency (USA)
GLP good laboratory practice
HPV high production volume (OECD program)
LC50 lethal concentration for 50% of the animals
LD50 lethal dose for 50% of the animals
LOEL lowest observed effect level
NIOH National Institute of Occupational Health (Sweden)
NIOSH National Institute for Occupational Safety and Health (USA)
NOEL no observed effect level
OECD Organization for Economic Cooperation and Development
RTECS Registry of Toxic Effects of Chemical Substances
SAP serum alkaline phosphatase
SGOT serum glutamic-oxaloacetic transaminase
SGPT serum glutamic-pyruvic transaminase
SIDS screening information data set (of OECD)
TLV threshold limit value
TMP trimethylolpropane
TWA time-weighted average
w/v weight/volume (g of substance in 100 ml solution)
w/w weight/weight (g of substance in 100 g solution)
1 INTRODUCTION
2-Ethyl-2-hydroxymethyl- 1,3-propanediol is a polyalcohol with three functional hydroxymethyl 
groups. The substance has several different chemical names and the most common synonym found 
in the literature is trimethylolpropane. This name is used in the present document.
At room temperature trimethylolpropane is a solid substance consisting of white crystal flakes 
with mild aromatic odor. The substance is listed by the Organization for Economic Cooperation 
and Development (OECD) Program of High Volume Products and its main use is as a solvent 
and intermediate in the production of resin and synthetic lubricating oil (14, 10).
Trimethylolpropane can affect humans by inhalation, via an oral route, or by contact exposure 
to skin and mucous membranes, either as solid powder, in liquid solution, or in vaporized form.
A literature search has been performed in medical and toxicological databases (Medline, 
Toxline, Riskline, Cancerlit, Chemical Abstracts, Healthline, NIOSHTIC, CISILO), resulting 
in 10 of the references listed in the present document.
The British Industrial Biological Research Association (BIBRA) conducted a Toxicity Profile 
on 1,1,1-trimethylolpropane in 1986 (3) and an OECD document was presented in 1993 (14). 
Most o f the original data on the toxicity of trimethylolpropane in these documents are from 
unpublished reports. The citations in these reviews are sometimes short, and therefore com­
plementary data from the original unpublished sources are included in the present document to 
give a more detailed description of test conditions.
Of the 18 references listed in the present survey on trimethylolpropane, five contain information 
about toxic effects of this substance in mammals. Only one describes toxicological data on humans.
2 PHYSICAL AND CHEMICAL PROPERTIES
Information about physical and chemical properties was obtained from references 5 ,1 0 ,1 3 , and
14. There is some confusion in the literature about the chemical structure of trimethylolpropane. 
The CAS Registry Number 77-99-6  has falsely been used for another substance, namely 
o,o,o-trimethyl-S-ethyl-phosphorothionate, in three of the references o f the literature search.
Chemical name: 2-Ethyl-2-hydroxymethyl-1,3-propanediol
CAS Registry Number: 77-99-6
Synonyms: 2,2 dihydroxymethylbutan-l-ol, Ethriol, 
ethyltrimethylolmethane, hexagly cerine 
hexaglycerol, TMP, l,l,l-tri(hydroxymethyl) 
propane, 1,1,1-trimethylolpropane
Molecular formula: C6H14O3
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Structural formula:
Molecular weight:
Physical state at room temperature: 
Melting point/Freezing point: 
Boiling point:
Vapor pressure:
Flash point (liquid):
Ignition temperature:
Bulk density:
Solubility in water:
Solubility in organic solvents:
Partition coefficient: 
(n-octanol/water) :
pH in water:
CH2OH
CH3CH2-C-CH2OH
CH2OH
134.18
White crystal flakes 
58-61°C
292°C at 101.3 kPa
0.02 Pa at 25°C 
1 Pa at 50°C 
67 Pa at 160°C
6.7 kPa at 210°C
172°C
375°C
0.590 g/cm3
Soluble. More than 100 g/1 at room 
temperature.
Freely soluble in glycerol, ethanol, and other 
lower alcohols. Forty grams of TMP soluble 
in 100 ml of acetone; 8 g in 100 ml of ethyl 
acetate and 0.02 g in 100 g of benzene. It is 
slightly soluble in carbon tetrachloride and 
chloroform. It is insoluble in aliphatic, 
aromatic, and chlorinated hydrocarbons.
log Pow=-0.47 (GC-analysis [14]) 
log Pow=-2.4 (calculated [14]) 
log Pow=-2.29 (calculated [12])
5.2 at a concentration of 250 g/1.
Trimethylolpropane is a white, crystalline substance that is mildly aromatic. In crystalline form, 
trimethylolpropane shows no decomposition at room temperature, but the substance has a strong 
hygroscopic property. Trimethylolpropane is totally soluble in water and has a half-life in 
solution of more than one year at pH 4.7 and 9.0, at 25°C (14).
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The industrial product contains no additives. Major impurities are trimethylolpropane- 
monomethylether and trimethylol-methylformal. According to one source the purity of 
trimethylolpropane as an industrial product is more than 99% (wt) (14).
In solid form trimethylolpropane is inflammable but a mixture o f dust and air is explosive at 
concentrations o f 2 % to 11.8 % by volume. At high temperature the substance vaporizes and 
forms a vapor/air mixture that is heavier than air and explosive in contact with hot surfaces, 
sparks, or flames.
3 USES AND OCCURRENCE
3.1 Production and Uses
Esters o f neopentyl polyols, e.g. trimethylolpropane, have been manufactured since 1940 by the 
IG Farbenindustrie (11). Trimethylolpropane contains only primary hydroxyl groups, no 
hydrogen in beta position and no tertiary hydrogen atoms, but a considerable degree of 
branching, and is therefore (together with other neopentyl polyols) used in the production of 
synthetic lubricant oils. Since 1960 these ester oils have gained special importance as high- 
temperature resistant lubricants for jet turbine engines. Because of the thermal properties these 
polyol esters are used today also as hydraulic fluids, rolling oil additives, heat exchange fluids, 
explosives, lubricating greases, and additives for silicones and silicate esters.
A variety o f chemicals may be added to these ester oils. Phosphorous additives are included as 
antiwear substances and metal deactivators. When used as synthetic aircraft engine lubricant 
it has been shown that thermal decomposition of trimethylolpropane-based oil forms a 
pyrolysate called trimethylolpropanephosphite (8, 18), also named 4-ethyl-l-phospa-2,6,7- 
trioxobicyclo(2,2,2)octane (4). This substance belongs to a class of highly neurotoxic com­
pounds, commonly referred to as bicyclophosphorous esters (18).
Trimethylolpropane is also used in the production o f polyurethanes and polyester resins. The 
first report on the formation of trimethylolpropane-phosphite came in 1975. It was a combustion 
product after pyrolysis o f a trimethylolpropane-based polyurethane foam, that had been treated 
with a phosphorous fire retardant (15). After these reports, the production o f trimethylolpropane- 
based urethanes has declined (10).
Trimethylolpropane is used in the production o f both alkyd coatings and acrylates. 
Trimethylolpropane-based acrylates and metacrylates are used in photocurable coatings, paints, 
varnishes and dental sealants. Multifunctional acrylates have a considerable chemical reactivity and 
are used in many applications with opportunities for contact exposure. They represent appreciable 
eye and skin contact hazards, and a number of multifunctional acrylates, such as trimethylolpropane 
triacrylate and trimethylolpropane trimetacrylate, have been identified as sensitizers (2, 7).
Trimethylolpropane can be formed by the reaction of n-butyraldehyde and formaldehyde 
together with sodium hydroxide in a condensation reaction. The intermediate 2,2-dimethylol- 
butyraldehyde formed by the aldol reaction is reduced with another molecule of formaldehyde
3
in a Cannizzaro reaction to give trimethylolpropane. Continuous closed systems are used and 
the final product is also extracted and purified during the processes (10, 14).
No published data on world production rates of trimethylolpropane have been found. An 
estimation o f the world production, and the Swedish production, was given by U. Rich (personal 
communication) at the Swedish Products Register at the National Chemical Inspectorate. His 
estimation of the world production level was approximately 100,000 metric tons per year, and 
there is one producer in Sweden, Perstorp AB, with a production of 20,000 metric tons per year.
According to the Japanese OECD report (14) the production level in Japan in 1991 was about
10,000 tons (not specified if  it is metric tons) per year. In 1991 about 2,000 tons of 
trimethylolpropane were imported to Japan. The major part was used for paint resin (7,500 tons), 
urethane resin (1,500 tons), setting resin by UV-ray (1,400 tons), synthetic lubricant oil (800 tons), 
and others (1,200 tons). Hoechst-Celanese Chemical Company is the only United States 
producer of trimethylolpropane with a plant at Bishop, Texas (10).
3.2 Occupational Exposure and Analytical Methods for Air Monitoring
No data were available on the present occupational exposure levels or techniques for sampling 
and analysis of trimethylolpropane in ambient air.
3.3 Present Occupational Standards
A Soviet study on the toxicology of trimethylolpropane (16) recommended a maximum permis­
sible concentration of 50 mg/m3 in factory air. This recommendation was based on studies on 
rats, where a subchronic inhalation experiment (3.5 months) shows an “arbitrary threshold 
concentration” of 0.13 mg/1 (130 mg/m3). What this expression stands for is unclear. The 
maximum permissible concentration of 50 mg/m3 in factory air was accepted by the Commission 
of the Ministry of Health of the USSR (9).
Neither an ACGIH TLV nor a German MAK value has been established. At present there are 
no standards or recommendations for occupational exposure to trimethylolpropane in Sweden. 
The present occupational standard for the respirable fraction o f dust and organic dust in 
Sweden is 5 mg/m3 (17). According to ACGIH a TLV, 8-hour TWA of 10 mg/m3 for 
particulates not otherwise classified has been established. The same value was adopted for 
nuisance particulates. A TLV, 8-hour TWA of 5 mg/m3 for respirable dust has also been 
established (1).
4 TOXICOKINETICS
There are no data on human uptake, distribution, biotransformation, or elimination of 
trimethylolpropane. In experimental animals no quantitative data were found on toxicokinetics.
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4.1 Uptake
In animals trimethylolpropane is absorbed via dermal, oral, and respiratory routes o f exposure. 
Systemic effects after dermal absorption have been observed. In an unpublished report, cited in 
BIBRA (3), trimethylolpropane was applied to closely clipped intact abdominal rabbit skin. 
After 24 hours there was residual substance at all dosage levels (2.15, 4.64, and 10.0 g/kg of 
b.wt.), except at the lowest (1.00 g/kg of b.wt.). Although no analysis was made on the amount 
of residual substance on the skin, the nonresidual part was assumed to have been absorbed by 
the skin. No systemic effects apart from kidney changes were observed.
No systemic effects were seen in mice after immersion of their tails in 50% solution (w/w or 
w/v not specified) of trimethylolpropane for 4 hours according to a Soviet study (16). In the 
same paper a test is described where 0.5 ml of 50% solution (the dose/kg • day was not specified) 
of trimethylolpropane was applied daily to the skin of rabbits for 3 months. No gross change in 
the general condition of the animals was observed. Histopathological data were not given.
An unpublished report from the German manufacturer, AG Bayer, cited by two reviews (3,14), 
indicated there were no signs of intoxication due to dermal resorption after a single dose of 
trimethylolpropane (0.5 g/kg b.wt.) was applied to the shaved nonabraded skin of rats. These 
dermal tests are further described in section 5.1.
In none of these dermal studies has the quantity of absorbed substance been estimated. 
Resorption through the skin has only been assumed or observed indirectly via clinical signs or 
morphological changes of internal organs.
4.2 Distribution, Biotransformation, and Elimination
No data are available.
5 GENERAL TOXICITY
No data on the general toxicity in humans have been found. In the literature available on 
trimethylolpropane, only toxic mechanisms causing a narcotic effect have been discussed (12).
5.1 Acute Toxicity
In laboratory animals the acute toxicity of trimethylolpropane is extremely low after oral 
administration, inhalation, and dermal exposure. The LC/LDso-values found in the literature on 
trimethylolpropane are listed in Table 1.
Test conditions of the different studies are described in Section 6, except for the following:
The first is an unpublished study cited in reference 14. Five male and five female Wistar rats 
received a single oral dose of 5 g/kg b.wt. of trimethylolpropane. The animals were observed 
for 14 days and no changes of body weights or clinical signs of toxicity were observed.
5
I a
Table 1. LD50/LC50  values in acute toxicity tests
Route of 
administration Species LD50/LC50* Reference
Oral Rat >2.5 g/kg Unpublished study cited in 
references 3 and 14
Oral Rat >5 g/kg Unpublished study cited in 
reference 14
Oral Rat 14.1 g/kg Reference 16
Oral Rat 14.7 g/kg Unpublished study cited in 
reference 3
Oral Mouse 13.7 g/kg Reference 16
Dermal Rat >0.5 g/kg Unpublished study cited in 
references 3 and 14
Dermal Rabbit >10 g/kg Unpublished study cited in 
reference 3
Inhalation Rat, mouse, 
rabbit, 
guinea pig
>290 mg/m3 • 4h Unpublished study cited in 
references 3 and 14
Inhalation Rat >700-2,000 mg/m3 . 4h Reference 16
The LC50 values are for inhalation studies and the LD50 values are for the other routes of administration.
The second study is unpublished and cited in reference 3 and 14. Twenty rats, 20 mice, 3 rabbits, 
and 5 guinea pigs were acutely exposed to an average ambient concentration of 0.29 mg 
trimethylolpropane/liter o f air (290 mg/m3) for 4 hours. No clinical signs of intoxication were 
observed during exposure or the 14-day observation period.
Clinical signs o f acute intoxication are mainly of narcotic (i.e., depressed respiration rate and 
reduced reflexes o f pain and placement) (reference 16 and unpublished study cited in reference 
3) or respiratory type (i.e. respiratory distress) (16).
Postmortem histological examination of animals that died after they were given lethal single 
oral doses (up to 21.5 g/kg b.wt.) o f trimethylolpropane showed hyperaemic lungs, irritation of 
the stomach, small intestine, and peritoneum (reference 16 and an unpublished study cited in 
reference 3). It could not be judged if death was caused by CNS-depression or damage to other 
internal organs.
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No chronic toxicity studies were found.
6 ORGAN EFFECTS
6.1 Skin and Mucous Membranes
The only data found on human tests on trimethylolpropane originate from the Encyclopedia of 
Chemical Technology (10), but the original source of information could not be obtained because 
of an error in the reference list of this encyclopedia. According to this source, patch tests were 
performed on 200 humans. These tests showed that trimethylolpropane is neither a primary skin 
irritant nor a skin sensitizer. No further data on test conditions were given in this short citation.
The effects of cutaneous application of trimethylolpropane to rabbits were evaluated by two 
Soviet studies (16). In one test 0.5 ml of 50% solution (w/w or w/v not specified) o f  
trimethylolpropane was applied daily to the skin of rabbits for 3 months. Contact time was not 
mentioned. In another test the tails of mice were immersed in 50% aqueous solution (w/w or 
w/v not specified) of trimethylolpropane for 4 hours. No visible changes of the skin at the site 
of application could be observed in these two tests. No information was given about test 
conditions such as the observation period, the number of animals tested, their gender, and strain, 
whether the skin was shaved or abraded, or whether animals were used as controls.
A 24-hour covered dermal exposure test is described in an unpublished report cited in BIBRA 
(3). Moistened trimethylolpropane was applied to the closely clipped intact abdominal skin of 
16 albino rabbits. Dosage levels were 1.0, 2.15, 4.64, and 10.0 g/kg b.wt., and the test material 
was removed after 24 hours. During the 7-day observation period all animals exhibited normal 
behavior and appearance. There was an increase in body weight in all animals and a very mild 
degree o f skin irritation occurred at each dosage level. The irritation was characterized at the 
end o f the exposure period by a mild erythema, which subsided within an additional day, after 
which the exposed skin area appeared grossly normal. Since no animals were used as controls 
and a mild degree of dermal irritation was observed at all dosage levels, no definite conclusion 
about the irritative effect can be made.
A 25% aqueous solution of trimethylolpropane was applied daily to the shaved unabraded skin 
of rats at a single dose of 0.5 g/kg of body weight as presented in an unpublished study cited in 
reference 3 and 14. Neither the number of animals used nor the contact time was mentioned. 
During 7 days o f observation of the animals, no signs of intoxication or irritation of the skin 
occurred.
In another study, cited by reference 3, cotton wool impregnated with trimethylolpropane was 
put inside the external ear o f two rabbits and one drop o f trimethylolpropane was put into the 
conjunctival sac of another rabbit. The rabbits were observed for 7 days without any signs of 
irritation to the skin or conjunctiva, or comeal damage. No data on the concentration or the 
contact time for the ear were mentioned.
5.2 Chronic Toxicity
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IThe BIBRA document (3) also presents brief information about eye irritancy, but the original 
studies are not published. According to one study, 50 mg trimethylolpropane was not irritating 
to the rabbit eye when observed for up to 7 days. The number of animals tested or other test 
conditions were not described in this short citation. There were indications of mild transient 
irritation (particularly in two animals) when 0.1 cm3 powder was introduced into the eye of nine 
rabbits. Four days after application there were no signs of irritation.
No inflammation of the skin or the mucous membrane of the eye was observed according to an 
unpublished study cited by an OECD document (14). A dose of 0.5 g of trimethylolpropane was 
put into the ear of two rabbits for 24 hours and 50 mg of trimethylolpropane was put into the 
conjunctival sac of the eye o f two rabbits.
6.2 Nervous System
Trimethylolpropane belongs chemically to a group of alcohols that are organic chemicals 
associated with narcotic-type toxicity. Human data are missing, but CNS depressive symptoms 
have been observed in experimental animals after exposure to trimethylolpropane. No data have 
been found on the toxicity to the peripheral nervous system.
A Soviet paper presents subchronic inhalation toxicity data for trimethylolpropane (16). This 
study is cited in a BIBRA document (3), which gives a description of this study as “obscure and 
poorly reported.”
Twenty albino rats (gender or strain not specified) were divided into two groups (size not given). 
The animals were exposed to either a concentration o f 100-700 mg/m3 (mean 130 mg/m3) or a 
concentration of 700-1,800 mg/m3 (mean 1,100 mg/m3). Exposure time was 4 hours per day in 
chambers during a period o f 3.5 months (it was not specified if it was for 7 or 5 days per week). 
The air supplied to the chambers passed through a tube, with the preparation placed in a boiling 
water bath, so as to resemble the technological process, where temperatures o f up to 100 °C 
are used. A dysfunction of the nervous system was described, measured by the threshold of 
neuromuscular excitability after electric stimuli. A raised threshold could be noticed after 
8 weeks o f exposure to trimethylolpropane at a concentration o f 1.1 mg/1 air (1,100 mg/m3). 
A concentration o f 0.13 mg/1 (130 mg/m3) caused “recorded shifts” beginning with the 
12th week. According to a BIBRA document (3), the results of this experiment remain obscure 
and can therefore not be evaluated. The effect of raised neuromuscular excitability was noticed 
earlier in the control animals than in the animals exposed to trimethylolpropane, according to 
the figures presented in the report.
A short-term experiment was also performed using the concentrations mentioned above 
(700-2,000 mg/m3), where an unspecified number of animals were exposed for 4 hours. No 
antemortem signs of toxicity were noticed but terminal histopathology revealed a “swelling of 
the cells” in some organs including the brain.
The report also describes signs of poisoning of the nervous system of rats after oral administra­
tion of trimethylolpropane. The symptoms were sluggishness, decreased respiration rate, and 
clonic-tonic spasms. Test conditions are poorly described. The number of animals tested was
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not given, and it was not mentioned if controls were used. Even data about actual doses at which 
these effects occurred are missing.
Inhibition of the central nervous system was observed in an unpublished study cited in BIBRA 
(3). Twenty-five male albino rats (strain not defined), divided into five groups, received 
trimethylolpropane orally at doses of 1 .0 ,2 .15,4 .64,10.0 , and 21.5 g/kg b.wt. No animals were 
used as controls. Within 1 to 2 hours after a single dose of 2.15 g/kg or more, the animals 
appeared depressed and exhibited lacrimation, slow and labored respiration, ataxia, and splaying 
of the legs. The animals at the 21.5 g/kg level all died and the premortal signs of intoxication 
were depressed or absent reflexes of pain, righting, and placement. Symptoms remained for 
24 hours; but at 43 hours following dosage, the surviving animals exhibited normal appearance 
and behavior.
6.3 Toxic Effects in Other Internal Organs
No human data have been found. Acute and repeated administration of trimethylolpropane to 
experimental animals has revealed toxic effects in internal organs, mainly the liver and the 
kidneys. The hepatotoxicity was manifested as general enlargement of the liver as well as 
enlarged hepatocytes and pericholangitis. Renal changes included increased kidney weight, 
deposits of proteinaceous material in the Bowmans space, and tubular nephrosis.
A Soviet paper (16) presents toxic effects on internal organs following inhalation of  
trimethylolpropane. Twenty albino rats were divided into two groups, exposed to either a 
concentration of 100-700 mg/m3 (mean 130 mg/m3) or a concentration of 700-1,800 mg/m3 
(mean 1,100 mg/m3). Exposure time was 4 hours per day in chambers during a period of
3.5 months. Test conditions are further described in section 6.2. The exposed rats displayed 
no grossly observable toxic signs, statistically significant difference of body weight, or any 
abnormal composition of peripheral blood (RBC, WBC, Hb, and differential count) in com­
parison with control animals. Histopathology of tissues from the final sacrifice revealed 
interstitial pneumonia, focal emphysema, and degeneration of the liver, heart, and kidneys. In 
addition, increased relative adrenal weights were present. The number of animals used and the 
strain were not described. No data were given on the use of controls or on the dose at which the 
effects occurred.
Another inhalation study performed on rats (6) did not show any toxic effects on internal organs 
at terminal autopsy. The animals (two male and two female Alderley-Park rats) inhaled 
trimethylolpropane at a concentration of 20 microgram/1 (20 mg/m3), 6 hours daily for 15 days. 
Urine tests (pH, sugar, protein, and specific gravity) and blood tests (electrolytes, urea, Hb, 
WBC, RBC, and differential count) were normal.
Changes in several internal organs were observed follow ing oral administration of 
trimethylolpropane to rats, according to an unpublished report cited in BIBRA (3) and OECD 
(14). Five groups, each consisting o f ten male and ten female Wistar rats were fed 
trimethylolpropane for 90 days at various dietary levels. The animals had intake levels of 
0, 0.03, 0.1, 0.3, and 1.0% from their food, which corresponds to approximately 20, 67, 200, 
and 667 mg/kg • day.
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IBiochemical analysis of blood revealed a significant decrease of hepatic enzymes (SGPT and 
SAP) at a dosage level o f200 mg/kg • day and above for male rats. Corresponding changes were 
also seen in female rats at a dosage level of 667 mg/kg • day. SGOT levels remained unchanged. 
After the administration of hepatotoxic substances there is usually an increase of liver enzymes 
in blood (e.g., SGPT and SGOT). Therefore no safe conclusions can be based on these results.
At a dose of 667 mg/kg • day there was a significant increase in the relative weight of the liver, 
kidneys, spleen, thyroid (female), adrenals (male), ovary, and brain (female) when compared 
with a nonexposed control group. There was no significant difference in terminal body weights 
between the various groups, including controls.
Morphological changes of liver and spleen were observed. Lymphocyte infiltration and nor­
moblasts were observed in the sinusoids of the liver at the highest dosage level (667 mg/kg). In 
female rats there were enlarged Kuppfer cells containing pigment granules at the highest dose 
level. Treatment-related changes in the spleen were also reported (hyperplasia of phagocytically 
active reticuloendothelial cells).
The subchronic oral toxicity of trimethylolpropane was investigated in sis strain Sprague- 
Dawley rats as presented in an unpublished report cited in OECD (14). The animals received 
doses of 0 to 800 mg/kg • day in distilled water. Before mating, the administration period was 
42 days for male rats and 14 days for female rats. Dosing of females continued after mating until 
day 3 of lactation. It is not specified in this short citation if it was for a consecutive number of 
days or 5 days per week. No deaths occurred among the 60 animals and no clinical signs 
attributable to the treatment were observed. Body weights of both male and female animals 
receiving 800 mg/day were lower than those of the control group. Liver weight (absolute and 
relative) was significantly elevated in rats of both sexes receiving 800 mg/kg • day. His- 
topathological examination revealed renal changes (slight tubular basophilic change of tubular 
epithelial cells) in male rats of all groups and in some of the females, but no dose-related 
morphological lesions of the liver or the kidneys were noticed.
Another unpublished study cited in OECD (14) showed significantly increased liver and kidney 
weights (absolute and relative) of rats (40 male and 40 female Wistar rats) after an oral dose of
2,000 mg/kg • day for 28 days. The animals were divided into four groups, each consisting of 
ten animals, with intake levels from their food of 0,0 .33,1.00, and 3.00 % (which corresponds 
to 0 ,220,667, and 2,000 mg/kg . day).
Treatment-related morphological changes (enlarged hepatocytes and pericholangitis) of the 
liver were seen at a dose of 667 mg/kg • day or more. Renal changes (minimal tubular 
nephrosis and deposits of a proteinaceous material in Bowmans space) were observed at a 
dose of 2,000 mg/kg . day.
Kidney changes (a hyperemic zone at the periphery of the medulla) were observed according to 
an unpublished report, cited in BIBRA (3). Twenty-five male albino rats (age and strain not 
specified) were given trimethylolpropane at doses of 1.0, 2.15, 4.64, 10.0, and 21.5 g/kg b.wt. 
as a single oral dose. No animals were used as controls. The kidney changes were observed at 
autopsy in all animals receiving 4.64 g/kg or more.
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■All animals given the highest dose died within 24 hours after administration, and autopsy showed 
hyperemic or hemorrhagic lungs, irritation of the pyloric portion of the stomach, small intestine, 
and peritoneum, as well as congested kidneys and adrenals. The acute oral LD5 0  o f 
trimethylolpropane was estimated to be 14.7 g/kg b.wt. (male albino rats).
7 ALLERGENIC PROPERTIES
Patch tests performed on 200 human subjects indicated that trimethylolpropane was not a skin 
sensitizer, according to a short citation in a chemical encyclopedia (10). The original report on 
this study could not be found and evaluated.
No other studies or case reports on the allergenic properties of trimethylolpropane were 
available.
8 GENOTOXICITY
Available data on the genotoxic effects of trimethylolpropane have not revealed any evidence 
of genotoxicity. All published information about genotoxicity in this section (exclusively in 
vitro tests for gene mutations) originates from one single secondary source of information, the 
OECD document (14).
Four different strains of Salmonella typhimurium (TA100, TA1535, TA98, TA1537) were 
tested, with and without an exogenous metabolic activation system (the S-9 mix from rat liver). 
Doses up to 5 mg of trimethylolpropane (99.51 % purity) per plate did not cause any bacteriotoxic 
effects or any evidence of mutagenic activity, in comparison with the negative controls.
A second study on the genotoxicity of trimethylolpropane was also negative (14). The short 
citation provided no information about the test method or genotoxic end-point. Test species were 
Salmonella typhimurium (strain TA98, TA100, TA1535, TA1537 and TA1538) and Escherichia 
coli (strain wp2 and uvrA).
The OECD document (14) also cites a third unpublished study which was negative. The short 
citation provides no information about test method. Test species were Salmonella typhimurium 
(strain TA98, TA100, TA1535, TA1537) and Escherichia coli (strain wp2 and uvrA). 
Mutagenicity was tested both with and without metabolic activation.
In a fourth unpublished study, cited in OECD (14), a nonbacterial in vitro test was performed 
on cultured Chinese hamster CHL cells. This short citation provides no information about test 
method or genotoxic end-point. The lowest concentration producing cell toxicity, both with and 
without metabolic activation, was 1.5 mg/ml. No genotoxic effect was observed.
9 CARCINOGENICITY
No information is available.
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I10 REPRODUCTIVE TOXICITY AND TERATOGENICITY
One citation of an unpublished report on the reproductive toxicity and teratogenicity of 
trimethylolpropane was available (14). Sprague-Dawley rats (strain sic) were given 
trimethylolpropane, in distilled water, by gavage. The administration period was 42 days prior 
to mating for male rats and from 14 days before mating to day 3 of lactation for female rats. A 
total number of 60 animals received doses from 0 to 800 mg/kg • day.
No significant toxic effects of test substance were observed on copulation, fertility, and oestrus 
cycles of rats. There was no increase in the incidence of abnormal pups and no effect on dams 
during the lactation period. Stillborn pups and pups killed at day 4 of the lactation period showed 
no gross abnormalities due to the treatment with trimethylolpropane.
11 DOSE-EFFECT AND DOSE-RESPONSE RELATIONSHIPS
The acute toxic effects found in the literature on trimethylolpropane are summarized in Table 2 
and the toxic effects of repeated exposure are summarized in Table 3.
12 RESEARCH NEEDS
There is a striking shortage of published material on trimethylolpropane. Most information 
originates from unpublished reports. Consequently, there is a need for peer-reviewed, published, 
experimental toxicological studies. Additional inhalation studies are especially needed to 
quantitatively estimate safe airborne exposures.
There is also an information gap concerning toxicological effects in humans. Only one source 
of information about toxicological effects in humans was found. No epidemiological studies on 
health status of workers chronically exposed to trimethylolpropane were available. Information 
about dermal, narcotic, hepatotoxic, and renal effects would be of great value.
Quantitative data on the toxicokinetics of the substance are absent. Studies on toxicokinetics, 
both on humans and animals, would be valuable to assess uptake, distribution, metabolism, and 
excretion.
13 DISCUSSION AND EVALUATION
Limited documentation exists of the toxic effects of trimethylolpropane in experimental animals. 
Many data originate from unpublished reports cited in reviews. Only two papers contained 
original information from toxicological studies on trimethylolpropane. One of these two reports 
gives a brief presentation of trimethylolpropane among 109 industrial chemicals, and the other 
is a Soviet paper (translated into English) that omits many data on test conditions and results. 
In an evaluation by BIBRA, this paper was described as obscure and poorly reported.
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aTable 2. Effects of acute exposure (<- 24 h)
Route of 
administration Species
Observed 
effect ^ Reference
Oral SD^ Rat Narcosis at 2.15 g/kg Reference 3
Oral SD Rat LD50>2.5 g References 3 and 14
Oral SD Rat Kidney changes at 4.64 g/kg b.wt. Reference 3
Oral SD Rat LD50>5 g/k b.wt. Reference 14
Oral SD Rat LD5 0  14.1g/kg b.wt. Reference 16
Oral SD Rat LD5 0  14.7 g/kg b.wt. Reference 3
Oral SD Mouse LD5 0  13.7 g/kg b.wt. Reference 16
Dermal SD Rat LD5o>0.5 g/kg b.wt. References 3 and 14
Dermal 24 h Rabbit Skin irritation at 1.0 g/kg b.wt/® Reference 3
Dermal 24 h Rabbit Kidney changes at 2.15 g/kg b.wt. Reference 3
Dermal 24 h Rabbit LD50>10 g/kg b.wt. Reference 3
Inhalation 4 h Rat LC5o>290 mg/m3 References 3 and 14
Inhalation 4 h Rat Congestion and altered vessel 
permeability at 700-2,000 mg/m3
Reference 16
* Lowest identified dose inducing effect.
^SD -  Single dose.
*This was the lowest dose used in the study. Skin irritation occurred at all doses, and no animals were used as controls.
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Table 3. Toxic effects after repeated exposure
Route of 
administration
Dose required for effect 
or measured entity Species
Observed
effect Reference
Oral 
(28 days)
LOEL 667 mg/kg • day 
NOEL 220 mg/kg • day
Rat Pericholangitis, enlarged 
hepatocytes
Reference
14
Oral 
(28 days)
LOEL 2000 mg/kg • day 
NOEL 667 mg/kg • day
Rat Renal changes, increased 
weight of liver and 
kidney.
Reference
14
Oral 
(6 weeks)
LOEL 800 mg/kg . day 
NOEL 200 mg/kg • day
Rat Increased rel weight of 
liver.
Reference
14
Oral 
(90 days)
LOEL 200 mg/kg • day (M) 
LOEL 667 mg/kg • day (F) 
NOEL 67 mg/kg . day (M) 
NOEL 200 mg/kg . day (F)
Rat Change of hepatic 
enzymes.
References 
3, 14
Oral 
(90 days)
LOEL 667 mg/kg • day 
NOEL 200 mg/kg . day
Rat Increase of phagocyti- 
cally active cells in 
spleen. Increased rel 
weights of liver, 
kidney, spleen, thyroid 
(F), adrenals (M), 
ovary and brain (F).
References 
3, 14
Oral 
(5 months)
>3,000 mg/kg • day Rat Mortality Reference
16
Inhalation 
(15 days)
>20 mg/m3 Rat No organ changes at 
autopsy.
Reference
6
Inhalation 
(3 months)
>700-1,800 mg/m3 Rat Mortality Reference
16
Inhalation 
(3.5 months)
100-700 mg/m3 Rat Increased neuromuscular 
excitability.
Reference
16
Inhalation 
(3.5 months)
100-1,800 mg/m3 Rat Pneumonia and emphy­
sema. Degeneration of 
liver, heart, and kidneys.
Reference
16
Inhalation 
(3.5 months)
700-1,800 mg/m3 Rat Increased rel weight of 
adrenals.
Reference
16
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No acute inhalation toxicity studies on experimental animals have shown any antemortem signs 
of poisoning. However, according to one study with concentrations ranging from 700 to
2,000 mg/m3, terminal histopathology revealed moderate congestion, a slight disturbance in the 
permeability of the vessel walls, and swelling of the cells of parenchymatous organs, including 
the brain. It is uncertain if these changes were significant since relevant data about test conditions 
were missing. To what extent trimethylolpropane actually is absorbed via the lungs was not 
investigated since no quantitative toxicokinetic measurements were performed.
In one study, rats were exposed to an aerosol of trimethylolpropane at 100 to 1,800 mg/m3 
for 3.5 months. Subsequent autopsies showed significantly increased relative weight of the 
adrenals. Histological changes of other internal organs were also noticed but it is uncertain if 
they were significant, because relevant data concerning test conditions were missing. Conse­
quently, there are no good-quality inhalation data on which to base any safe occupational 
exposure limit.
The acute oral toxicity of trimethylolpropane in experimental animals is extremely low. The 
lowest oral LD5 0  value found was 13.7 g/kg b.wt. in mice. In rats the lowest oral LD5 0  value 
was 14.1 g/kg b.wt. Signs of acute poisoning were noted in the nervous system and some 
internal organs. The CNS effects were mainly of the narcotic type (e.g., drowsiness, decreased 
respiration rate, and ataxia). These effects were never seen at oral doses lower than 2.25 g/kg in 
rats. A physiological narcotic-type reaction could be theoretically anticipated, since this is a 
well-known effect of other alcohols.
Autopsy of animals that died after they were given high oral doses of trimethylolpropane showed 
irritation of the gastrointestinal tract, and congested lungs and kidneys. The lowest single oral 
dose given to animals where morphological changes of internal organs were demonstrated was
4.6 g/kg b.wt. (significant changes in kidney structure of rats).
An oral dose of 667 mg/kg • day to rats for 3 months caused significant enlargement of the liver, 
kidneys, and spleen. Rats fed trimethylolpropane for 28 days had pericholangitis and enlarged 
hepatocytes at a dose of 667 mg/kg • day or more and tubular nephrosis at a dose of 2 g/kg • day 
(significant effects).
Although trimethylolpropane belongs chemically to the group of alcohols of which many are 
considered toxicologically nonreactive, theoretically some suspicion could be raised about 
irritative effects of trimethylolpropane. Trihydric alcohols are used for their reactive properties 
and are used as reagents in the production of plastics such as polyurethanes and multifunctional 
acrylates. Furthermore, a dissolution effect could reduce the protective fatty layer of the skin. 
Experimental data on the other hand indicate a mild acute dermal irritative effect in animals. 
Actually only one study (on rabbits) showed any irritative effect at all and the results of this 
study can be questioned since irritation of the skin occurred at all dosage levels and no animals 
were used as controls. Patch tests performed on humans did not reveal any irritative or allergenic 
effects of trimethylolpropane.
The observed effects following acute exposure to very high doses of trimethylolpropane are 
damage to internal organs (kidney changes and irritation of the gastrointestinal tract) and signs
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of CNS depression. Long-term effects are changes of internal organs such as enlargement of the 
lungs, liver, kidneys, and spleen as well as some histological changes in these organs, but no 
conclusion about a critical effect can be made because of insufficient data.
14 SUMMARY
R Wälinder: NIOH and NIOSH Basis for an Occupational Health Standard: 2-Ethyl-2- 
hydroxymethyl-1,3-propanediol. Arbete och Hälsa 1994:10
This document is a survey of the literature on 2-ethyl-2-hydroxymethyl-1,3-propanediol, also 
called 1,1,1-trimethylolpropane, as well as an evaluation of data that is relevant for establishing 
occupational exposure limits.
In experimental animals, 1,1,1-trimethylolpropane seems to be of low toxicity. The toxic effects 
in experimental animals, following both acute and repeated exposures, are depression of the 
central nervous system together with hepatic and renal changes. No conclusion about the critical 
effect or dose can be made because of insufficient data.
Limited studies have revealed mild irritative dermal effects in animals but no convincing 
evidence of irritation in exposed humans. Epidemiological studies or case reports on workers 
occupationally exposed to 1,1,1-trimethylolpropane have not been found. Limited in vitro tests 
did not show any signs of genotoxicity. No studies on carcinogenicity were available. 18 
references.
Key-words: 2-ethyl-2-hydroxymethyl-1,3-propanediol; 1,1,1-trimethylolpropane; occupational 
exposure limits; CNS-effects; hepatotoxicity; renal toxicity.
15 SAMMANFATTNING
R Wälinder: NIOH and NIOSH Basis for an Occupational Health Standard: 2-Ethyl-2-
hydroxymethyl-1,3-propanediol. Arbete och Hälsa 1994:10.
I detta dokument redovisas en sammanställning av tillgänglig litteratur om 2-etyl-2- 
hydroxymetyl-l,3-propandiol, även kallad 1,1,1-trimetylolpropan, och en utvärdering av de 
datauppgifter som bedöms vara relevanta för fastställande av ett hygieniskt gränsvärde for 
yrkesmässig exponering.
Toxiciteten hos 1,1,1-trimetylolpropan förefaller att vara lag hos försöksdjur. De toxiska 
effektema hos försöksdjur, efter bade akut och upprepad tillförsel, är päverkan pä centrala 
nervsystemet tillsammans med lever och njurförändringar. En slutsats om kritisk effekt eller dos 
gar inte att dra pga otillräckligt dataunderlag.
Data frän ett begränsat antal studier har visat en lätt hudirritativ effekt hos djur men inga 
övertygande bevis om hudirritativa effekter hos människor. Epidemiologiska studier eller 
fallrapporter om arbetare som exponeras för 1,1,1-trimetylolpropan i yrket har ej hittats. Enligt
16
aett begränsat antal in vitro tester künde genotoxiska effekter ej pävisas. Inga studier om
kancerframkallande egenskaper var tillgängliga. 18 referenser.
Nyckelord: 2-etyl-2-hydroxym etyl-l,3-propandiol; 1,1,1-trimetylolpropan; hygieniska
gränsvärden; centralnervösa effekter; levertoxicitet; njurtoxicitet.
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